Khanna S, Chaudhary D, Kumar A, Vij J C
Department of Gastroeneterology and Hepatology, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, Press Enclave Road, Shiekh Sarai-II, New Delhi 110017, India.
Eur J Clin Microbiol Infect Dis. 2005 Jun;24(6):428-30. doi: 10.1007/s10096-005-1338-2.
The study presented here was performed to evaluate the need for aspiration in patients with amebic liver abscess (ALA). Patients older than 12 years with a diagnosis of ALA based on clinical features, ultrasound results, and positive amebic serology were included in the study (n=144). Serological testing was performed to detect the presence of immunoglobin G antibody against Entamoeba histolytica, and a value of more than 0.4 optical density units was considered positive. All patients were given intravenous metronidazole (500 mg every 8 h) and their clinical progress and need for abscess aspiration was documented. Fever, pain in the upper abdomen, and tender hepatomegaly was seen in 133 (92.3%), 128 (88.8%), and 144 (100%) patients, respectively. Multiple abscesses were seen in 40 (27.7%) patients. Six (4.1%) patients died. Seventy-one (49.3%) patients responded to metronidazole alone. A total of 73 (50.69%) patients required aspiration of the abscess. This study shows that almost 50% of the patients with amebic liver abscess failed to respond to metronidazole and required aspiration.
本研究旨在评估阿米巴肝脓肿(ALA)患者是否需要进行穿刺引流。本研究纳入了12岁以上、基于临床特征、超声检查结果及阿米巴血清学阳性确诊为ALA的患者(n = 144)。进行血清学检测以检测抗溶组织内阿米巴免疫球蛋白G抗体的存在,光密度单位值大于0.4被视为阳性。所有患者均接受静脉注射甲硝唑(每8小时500 mg),并记录其临床进展及脓肿穿刺引流的必要性。分别有133例(92.3%)、128例(88.8%)和144例(100%)患者出现发热、上腹部疼痛和肝脏肿大压痛。40例(27.7%)患者出现多个脓肿。6例(4.1%)患者死亡。71例(49.3%)患者仅对甲硝唑有反应。共有73例(50.69%)患者需要进行脓肿穿刺引流。本研究表明,近50%的阿米巴肝脓肿患者对甲硝唑无反应,需要进行穿刺引流。